Anesthetic

General anesthetics

Inhaled agents

• Desflurane (common)
• Enflurane (largely discontinued)
• Halothane (inexpensive, discontinued)
• Isoflurane (common)
• Methoxyflurane
• Nitrous oxide
• Sevoflurane (common)
• Xenon (rarely used)

Volatile agents are typically organic liquids that evaporate readily. They are given by inhalation for induction or maintenance of general anesthesia. Nitrous oxide and xenon are gases, so they are not considered volatile agents. The ideal volatile anesthetic should be non-flammable, non-explosive, and lipid-soluble. It should possess low blood gas solubility, have no end-organ (heart, liver, kidney) toxicity or side-effects, should not be metabolized, and should not irritate the respiratory pathways.

No anaesthetic agent currently in use meets all these requirements, nor can any anaesthetic agent be considered completely safe. There are inherent risks and drug interactions that are specific to each and every patient. The agents in widespread current use are isoflurane, desflurane, sevoflurane, and nitrous oxide. Nitrous oxide is a common adjuvant gas, making it one of the most long-lived drugs still in current use. Because of its low potency, it cannot produce anesthesia on its own but is frequently combined with other agents. Halothane, an agent introduced in the 1950s, has been almost completely replaced in modern anesthesia practice by newer agents because of its shortcomings. Partly because of its side effects, enflurane never gained widespread popularity.

In theory, any inhaled anesthetic agent can be used for induction of general anesthesia. However, most of the halogenated anesthetics are irritating to the airway, perhaps leading to coughing, laryngospasm and overall difficult inductions. If induction needs to be conducted with an inhaled anesthetic agent, sevoflurane is often used due to a relatively low pungency, rapid increase in alveolar concentration, and a higher blood solubility than other agents. These properties allow for a less irritating and quicker induction as well as a rapid emergence from anesthesia compared to other inhaled agents. All of the volatile agents can be used alone or in combination with other medications to maintain anesthesia (nitrous oxide is not potent enough to be used as a sole agent).

Volatile agents are frequently compared in terms of potency, which is inversely proportional to the minimum alveolar concentration. Potency is directly related to lipid solubility. This is known as the Meyer-Overton hypothesis. However, certain pharmacokinetic properties of volatile agents have become another point of comparison. Most important of those properties is known as the blood/gas partition coefficient. This concept refers to the relative solubility of a given agent in blood. Those agents with a lower blood solubility (i.e., a lower blood–gas partition coefficient; e.g., desflurane) give the anesthesia provider greater rapidity in titrating the depth of anesthesia, and permit a more rapid emergence from the anesthetic state upon discontinuing their administration. In fact, newer volatile agents (e.g., sevoflurane, desflurane) have been popular not due to their potency (minimum alveolar concentration), but due to their versatility for a faster emergence from anesthesia, thanks to their lower blood–gas partition coefficient.

Intravenous agents (non-opioid)

While there are many drugs that can be used intravenously to produce anesthesia or sedation, the most common are:

• Barbiturates
  • Amobarbital (trade name: Amytal)
  • Methohexital (trade name: Brevital)
  • Thiamylal (trade name: Surital)
  • Thiopental (trade name: Penthothal, referred to as thiopentone in the UK)
• Benzodiazepines
  • Diazepam
  • Lorazepam
  • Midazolam
• Etomidate
• Ketamine
• Propofol

Among the barbiturates mentioned above, thiopental and methohexital are ultra-short-acting and are used to induce and maintain anesthesia. However, though they produce unconsciousness, they provide no analgesia (pain relief) and must be used with other agents. Benzodiazepines can be used for sedation before or after surgery and can be used to induce and maintain general anesthesia. When benzodiazepines are used to induce general anesthesia, midazolam is preferred. Benzodiazepines are also used for sedation during procedures that do not require general anesthesia. Like barbiturates, benzodiazepines have no pain-relieving properties.

Etomidate is one of the most commonly used intravenous drugs employed to induce and maintain general anesthesia. It can also be used for sedation during procedures or in the ICU. Like the other agents mentioned above, it renders patients unconscious without producing pain relief. Compared to other IV agents, etomidate causes minimal depression of the cardiopulmonary system. Additionally, etomidate results in a reduction in intracranial pressure and cerebral blood flow. Because of these favorable physiological effects, was a favored agent in the ICU. However, etomidate has since been shown to produce adrenocortical suppression, resulting in decreased use to avoid an increased mortality rate in severely ill patients. Ketamine is infrequently used in anesthesia because of the unpleasant experiences that sometimes occur on emergence from anesthesia, which include "vivid dreaming, extracorporeal experiences, and illusions." When it is used, it is often paired with a benzodiazepine such as midazolam for amnesia and sedation. However, like etomidate it is frequently used in emergency settings and with sick patients because it produces fewer adverse physiological effects. Unlike the intravenous anesthetic drugs previously mentioned, ketamine produces profound pain relief, even in doses lower than those that induce general anesthesia. Also unlike the other anesthetic agents in this section, patients who receive ketamine alone appear to be in a cataleptic state, unlike other states of anesthesia that resemble normal sleep. Ketamine-anesthetized patients have profound analgesia but keep their eyes open and maintain many reflexes.

Intravenous opioid analgesic agents

While opioids can produce unconsciousness, they do so unreliably and with significant side effects. So, while they are rarely used to induce anesthesia, they are frequently used along with other agents such as intravenous non-opioid anesthetics or inhalational anesthetics. Furthermore, they are used to relieve pain of patients before, during, or after surgery. The following opioids have short onset and duration of action and are frequently used during general anesthesia:

• Alfentanil
• Fentanyl
• Remifentanil
• Sufentanil, which is not available in Australia.

The following agents have longer onset and duration of action and are frequently used for post-operative pain relief:

• Buprenorphine
• Butorphanol
• Diamorphine, also known as heroin, not available for use as an analgesic in any country but the UK.
• Hydromorphone
• Levorphanol
• Pethidine, also called meperidine in North America.
• Methadone
• Morphine
• Codeine
• Nalbuphine
• Oxycodone, not available intravenously in U.S.
• Oxymorphone
• Pentazocine

Muscle relaxants

Muscle relaxants do not render patients unconscious or relieve pain. Instead, they are sometimes used after a patient is rendered unconscious (induction of anesthesia) to facilitate intubation or surgery by paralyzing skeletal muscle.These agents fall into two categories: depolarizing agents, which depolarize the motor end plate to prevent further stimulation, and non-depolarizing agents, which prevent acetylcholine receptor activation through competitive inhibition.

• Depolarizing muscle relaxants
  • Succinylcholine (also known as suxamethonium in the UK, New Zealand, Australia and other countries, "Celokurin" or "celo" for short in Europe)
  • Decamethonium
• Non-depolarizing muscle relaxants
  • Short acting
    • Mivacurium
    • Rapacuronium
  • Intermediate acting
    • Atracurium
    • Cisatracurium
    • Rocuronium
    • Vecuronium
  • Long acting
    • Alcuronium
    • Doxacurium
    • Gallamine
    • Metocurine
    • Pancuronium
    • Pipecuronium
    • Tubocurarine

A potential complication where neuromuscular blockade is employed is 'anesthesia awareness'. In this situation, patients paralyzed may awaken during their anesthesia, due to an inappropriate decrease in the level of drugs providing sedation or pain relief. If this is missed by the anesthesia provider, the patient may be aware of their surroundings, but be incapable of moving or communicating that fact. Neurological monitors are increasingly available that may help decrease the incidence of awareness. Most of these monitors use proprietary algorithms monitoring brain activity via evoked potentials. Additionally, anesthesia providers often have steps they follow to help prevent awareness, such as ensuring all equipment is working properly, monitoring that drugs are being delivered during surgery, and asking a series of questions (the Brice questions) to help detect awareness after surgery. If there is any suspicion of patient awareness, close follow-up and mental health professionals can help manage or avoid any traumatic stress associated with the awareness. Certain procedures, such as endoscopies or colonoscopies, are managed a technique called conscious sedation or monitored anesthesia care. These cases are performed with regional anesthetics and a "twilight sleep" achieved through sedation with propofol and analgesics, and patients may remember perioperative events. When this technique is used, patients should be advised that this is management is distinct from general anesthesia to help combat any belief or fear that they were "awake" during anesthesia.

Intravenous reversal agents

• Flumazenil, reverses the effects of benzodiazepines
• Naloxone, reverses the effects of opioids
• Neostigmine, helps to reverse the effects of non-depolarizing muscle relaxants
• Sugammadex, helps to reverse the effects of non-depolarizing muscle relaxants